Our Facilities

In our state-of-the-art facilities of in total >1,500 square meters (>15,000 square feet), we can handle large volumes of samples, while maintaining our unprecedented precision and depth. We can deliver many projects in parallel and routinely perform studies with over 1,000 samples for global pharma and biotech customers, academia, or consortia.

We process and store data with utmost protection and operate under comprehensive quality standards. Our Quality Management System (QMS) follows the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH E6) guidelines for GCP, and we are also GLP-like compliant with the lab operation services. This allows us to support our customers in the implementation of proteomics in clinical trials.

We stand for flexibility as well as scalability. We are flexible to support projects of different sizes and sample numbers, depending on the customer’s need. We operate at large scale according to today’s standards, and we are also fully equipped and capable to continuously scale up our throughput to support the rising capacity needs for large-scale proteomics in the future.

From our two facilities, we invent and develop proprietary mass spectrometry-based proteomics technologies and offer a broad range of cutting-edge proteomics solutions. We make these widely available to life science researchers and proteomics experts to make the proteome more accessible.